A share price of Achieve Life Sciences Inc [ACHV] is currently trading at $5.19, up 4.43%. An important factor to consider is whether the stock is rising or falling in short-term value. The ACHV shares have gain 15.72% over the last week, with a monthly amount glided 6.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Achieve Life Sciences Inc [NASDAQ: ACHV] stock has seen the most recent analyst activity on November 25, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $19. Previously, H.C. Wainwright started tracking the stock with Buy rating on August 21, 2025, and set its price target to $12. On November 14, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $12 on the stock. Raymond James started tracking the stock assigning a Strong Buy rating and suggested a price target of $20 on September 27, 2024. Maxim Group reiterated its recommendation of a Buy and raised its price target to $20 on May 10, 2023. Oppenheimer started tracking with a Outperform rating for this stock on June 23, 2021, and assigned it a price target of $23.
Achieve Life Sciences Inc experienced fluctuations in its stock price throughout the past year between $1.84 and $5.78. Currently, Wall Street analysts expect the stock to reach $4.75 within the next 12 months. Achieve Life Sciences Inc [NASDAQ: ACHV] shares were valued at $5.19 at the most recent close of the market. An investor can expect a potential drop of -8.48% based on the average ACHV price forecast.
Analyzing the ACHV fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -1.97 and Total Capital is -1.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.97 points at the first support level, and at 4.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.35, and for the 2nd resistance point, it is at 5.50.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Achieve Life Sciences Inc [NASDAQ:ACHV] is 5.14. On the other hand, the Quick Ratio is 5.14, and the Cash Ratio is 3.28.
Transactions by insiders
Recent insider trading involved Oki Mark K, Chief Financial Officer, that happened on Sep 18 ’25 when 50060.0 shares were sold. Chief Executive Officer, Stewart Richard Alistair completed a deal on Sep 18 ’25 to sell 0.13 million shares. Meanwhile, Principal Accounting Officer Wan Jerry sold 14070.0 shares on Sep 04 ’25.
